Accession | ARO:3007858 |
Definition | BIM is a family of ambler molecular class B beta-lactamases from Pseudomonas putida. It confers resistance to carbapenems and cephalosporins. |
Drug Class | carbapenem, cephalosporin |
Resistance Mechanism | antibiotic inactivation |
Classification | 10 ontology terms | Show + process or component of antibiotic biology or chemistry + mechanism of antibiotic resistance + determinant of antibiotic resistance + antibiotic inactivation [Resistance Mechanism] + antibiotic inactivation enzyme + hydrolysis of antibiotic conferring resistance + antibiotic molecule + hydrolysis of beta-lactam antibiotic by metallo-beta-lactamase + beta-lactam antibiotic + beta-lactamase |
Parent Term(s) | 3 ontology terms | Show + confers_resistance_to_drug_class carbapenem [Drug Class] + confers_resistance_to_drug_class cephalosporin [Drug Class] + class B (metallo-) beta-lactamase |
Sub-Term(s) | 1 ontology terms | Show + BIM-1 |
Publications | Souza CO, et al. 2023. J Antimicrob Chemother 78(6):1359-1366 Genetic and biochemical characterization of BIM-1, a novel acquired subgroup B1 MBL found in a Pseudomonas sp. strain from the Brazilian Amazon region. (PMID 37038995) |
Curator | Description | Most Recent Edit |
---|